Low-dose bacille Calmette–Guérin for non-muscle-invasive bladder cancer: Results of a prospective study
Conclusion Low-dose BCG intravesical therapy is an effective adjuvant treatment in NMIBC. However, this needs to be validated in future studies and in comparison with other proposed doses and/or regimens.
Source: Arab Journal of Urology - Category: Urology & Nephrology Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Carcinoma | Middle East Health | Study | Transitional Cell Carcinoma | Urology & Nephrology